Â鶹´«Ã½

  • By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.
OK
Advertisement
In the last 7 days
House Committee on Oversight and Reform10:21 17-Sep-24
House Committee on Oversight and Reform10:21 17-Sep-24
Political Wire07:14 16-Sep-24
Just The News19:29 13-Sep-24
Fox News18:18 13-Sep-24
Fox News17:47 13-Sep-24
The Daily Caller17:13 13-Sep-24
C-Span (Video)11:05 13-Sep-24
In the last month
Maryland Matters23:33 12-Sep-24
Washingtonian07:16 12-Sep-24
Maryland Matters21:13 11-Sep-24
The National Pulse17:02 4-Sep-24
Roll Call15:54 3-Sep-24
The Washington Times12:16 31-Aug-24
Chicago Reader14:36 29-Aug-24
Chicago Sun-Times20:15 23-Aug-24
The Raw Story06:06 23-Aug-24
Maryland Matters00:00 23-Aug-24
C-Span (Video)16:37 22-Aug-24
C-Span (Video)16:06 22-Aug-24
Yahoo! UK & Ireland02:19 22-Aug-24
C-Span (Video)21:58 21-Aug-24
The Raw Story14:00 20-Aug-24
view more headlines
17 Sep 10:21

About our Jamie Raskin news

Latest news on Jamie Raskin, an American lawyer and politician serving as the U.S. representative for Maryland's 8th congressional district. He is a member of the Democratic Party and has served in this role since 2017. In Congress, Raskin is the chair of the Subcommittee on Civil Rights and Civil Liberties and the co-chair of the Congressional Freethought Caucus. He was also the lead impeachment manager for the second impeachment of President Donald Trump. Prior to his time in Congress, Raskin was a constitutional law professor at American University Washington College of Law and co-founded the LL.M. program on law and government and the Marshall-Brennan Constitutional Literacy Project. In December 2022, Raskin announced that he had been diagnosed with diffuse large B-cell lymphoma and would undergo chemotherapy and immunotherapy treatment.


Publication filters

Headline Density

Sorry, no headlines or news topics were found. Please try different keywords.